The purpose of "Social Construction of Benefit in Gene Transfer Research" was to determine how the prospect of direct benefit to research subjects in gene transfer research (GTR) (usually called "gene therapy") is understood and discussed by research subjects, investigators, study coordinators, and IRBs, and explained in consent forms.  All studies were on a list of gene transfer protocols registered with the Recombinant DNA Advisory Committee, Office of Biotechnology Activities of the NIH.   "Influence and Benefit in Gene Transfer Research" is a competitive renewal of "Social Construction of Benefit in Gene Transfer Research."

The study had three components (also see organizational chart and project instruments):

Products of this study are listed in Project Publications and Presentations.